{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T11:40:27Z","timestamp":1688557227467},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,10,17]],"date-time":"2013-10-17T00:00:00Z","timestamp":1381968000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1471-2334-13-482","type":"journal-article","created":{"date-parts":[[2013,10,17]],"date-time":"2013-10-17T15:03:05Z","timestamp":1382022185000},"source":"Crossref","is-referenced-by-count":11,"title":["Nevirapine versus efavirenz-based antiretroviral therapy regimens in antiretroviral-naive patients with HIV and tuberculosis infections in India: a pilot study"],"prefix":"10.1186","volume":"13","author":[{"given":"Sanjeev","family":"Sinha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Puroshottam","family":"Raghunandan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahul","family":"Chandrashekhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surendra K","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjiv","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sahajal","family":"Dhooria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meera","family":"Ekka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thirumurthy","family":"Velpandian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay","family":"Ranjan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hafeez","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jyotish Chandra","family":"Samantaray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srinivasaraghavan","family":"Venkatesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bharat Bhushan","family":"Rewari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nawaid Hussain","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravindra Mohan","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,10,17]]},"reference":[{"key":"4198_CR1","volume-title":"Global report: UNAIDS report on the global AIDS epidemic","author":"Joint United Nations Programme on HIV\/AIDS","year":"2010","unstructured":"Joint United Nations Programme on HIV\/AIDS: Global report: UNAIDS report on the global AIDS epidemic. 2010, Geneva, Available: http:\/\/www.unaids.org\/en\/media\/unaids\/contentassets\/documents\/unaidspublication\/2010\/20101123_globalreport_en.pdf ."},{"key":"4198_CR2","volume-title":"Global tuberculosis report 2012","author":"World Health Organization","year":"2012","unstructured":"World Health Organization: Global tuberculosis report 2012. 2012, Geneva, Available: http:\/\/www.who.int\/tb\/publications\/global_report\/en\/"},{"key":"4198_CR3","volume-title":"National AIDS control organization: annual report 2011\u201312","author":"National AIDS Control Organisation India, Department of AIDS Control, Ministry of Health & Family Welfare","year":"2013","unstructured":"National AIDS Control Organisation India, Department of AIDS Control, Ministry of Health & Family Welfare: National AIDS control organization: annual report 2011\u201312. 2013, New Delhi, Available: http:\/\/aidsdatahub.org\/en\/india-reference-library\/item\/23889-annual-report-2011-12-national-aids-control-organisation-india-department-of-aids-control%20%E2%80%94%20ministry-of-health%20%E2%80%94%20family-welfare-2012"},{"key":"4198_CR4","volume-title":"Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach","author":"World Health Organization","year":"2010","unstructured":"World Health Organization: Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach. 2010, Geneva, Available: http:\/\/whqlibdoc.who.int\/publications\/2010\/9789241599764_eng.pdf"},{"key":"4198_CR5","volume-title":"Antiretroviral therapy guidelines for HIV-infected adults and adolescents including post-exposure prophylaxis","author":"National AIDS Control Organisation, Ministry of Health & Family Welfare, India","year":"2007","unstructured":"National AIDS Control Organisation, Ministry of Health & Family Welfare, India: Antiretroviral therapy guidelines for HIV-infected adults and adolescents including post-exposure prophylaxis. 2007, New Delhi, Available: http:\/\/www.who.int\/bulletin\/volumes\/88\/3\/09-068759\/en\/"},{"key":"4198_CR6","doi-asserted-by":"publisher","first-page":"819","DOI":"10.2165\/00003088-200342090-00003","volume":"42","author":"M Niemi","year":"2003","unstructured":"Niemi M, Backman JT, Fromm MF, Neuvonen PJ, Kivist\u00f6 KT: Pharmacokinetic interactions with rifampicin: clinical relevance. Clin Pharmacokinet. 2003, 42: 819-850. 10.2165\/00003088-200342090-00003.","journal-title":"Clin Pharmacokinet"},{"key":"4198_CR7","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1093\/jac\/dkm484","volume":"61","author":"K Cohen","year":"2008","unstructured":"Cohen K, Cutsem van G, Boulle A, McIlleron H, Goemaere E, Smith PJ, Maartens G: Effect of rifampicin-based antitubercular therapy on nevirapine plasma concentrations in south African adults with HIV-associated tuberculosis. J Antimicrob Chemother. 2008, 61: 389-393.","journal-title":"J Antimicrob Chemother"},{"key":"4198_CR8","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1177\/135965350701200406","volume":"12","author":"JJG Van Oosterhout","year":"2007","unstructured":"Van Oosterhout JJG, Kumwenda JJ, Beadsworth M, Mateyu G, Longwe T, Burger DM, Zijlstra EE: Nevirapine-based antiretroviral therapy started early in the course of tuberculosis treatment in adult Malawians. Antivir Ther. 2007, 12: 515-521.","journal-title":"Antivir Ther"},{"key":"4198_CR9","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/j.1468-1293.2008.00563.x","volume":"9","author":"W Manosuthi","year":"2008","unstructured":"Manosuthi W, Mankatitham W, Lueangniyomkul A, Chimsuntorn S, Sungkanuparph S: Standard-dose efavirenz vs. Standard-dose nevirapine in antiretroviral regimens among HIV-1 and tuberculosis co-infected patients who received rifampicin. HIV Med. 2008, 9: 294-299. 10.1111\/j.1468-1293.2008.00563.x.","journal-title":"HIV Med"},{"key":"4198_CR10","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1742-6405-8-41","volume":"8","author":"S Sinha","year":"2011","unstructured":"Sinha S, Dhooria S, Kumar S, Shah N, Velpandian T, Ravi A, Kumar N, Ahmad H, Bhargwa A, Chug K, Bumma N, Chandrashekhar R, Ekka M, Sreenivas V, Sharma SK, Samantaray J, Mitsuyasu R: The antiretroviral efficacy of highly active antiretroviral therapy and plasma nevirapine concentrations in HIV-TB co-infected Indian patients receiving rifampicin based antituberculosis treatment. AIDS Res Ther. 2011, 8: 41-10.1186\/1742-6405-8-41.","journal-title":"AIDS Res Ther"},{"key":"4198_CR11","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/S0140-6736(04)15997-7","volume":"363","author":"F Van Leth","year":"2004","unstructured":"Van Leth F, Phanuphak P, Ruxrungtham K, Baraldi E, Miller S, Gazzard B, Cahn P, Lalloo UG, van der Westhuizen IP, Malan DR, Johnson MA, Santos BR, Mulcahy F, Wood R, Levi GC, Reboredo G, Squires K, Cassetti I, Petit D, Raffi F, Katlama C, Murphy RL, Horban A, Dam JP, Hassink E, van Leeuwen R, Robinson P, Wit FW, Lange JMA, 2NN Study team: Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study. Lancet. 2004, 363: 1253-1263. 10.1016\/S0140-6736(04)15997-7.","journal-title":"Lancet"},{"key":"4198_CR12","doi-asserted-by":"crossref","unstructured":"Mbuagbaw LC, Irlam JH, Spaulding A, Rutherford GW, Siegfried N: Efavirenz or nevirapine in three-drug combination therapy with two nucleoside-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-na\u00efve individuals. Cochrane Database Syst Rev. 2010, CD004246-doi:10.1002\/ 14651858.CD004246.pub3, 12","DOI":"10.1002\/14651858.CD004246.pub3"},{"key":"4198_CR13","volume-title":"The treatment of tuberculosis guidelines","author":"World Health Organization, Stop TB Initiative","year":"2010","unstructured":"World Health Organization, Stop TB Initiative: The treatment of tuberculosis guidelines. 2010, Geneva, Available: http:\/\/www.who.int\/tb\/features_archive\/new_treatment_guidelines_may2010\/en\/index.html"},{"key":"4198_CR14","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1001\/jama.300.5.530","volume":"300","author":"A Boulle","year":"2008","unstructured":"Boulle A, Van Cutsem G, Cohen K, Hilderbrand K, Mathee S, Abrahams M, Goemaere E, Coetzee D, Maartens G: Outcomes of nevirapine- and efavirenz-based antiretroviral therapy when coadministered with rifampicin-based antitubercular therapy. JAMA. 2008, 300: 530-539. 10.1001\/jama.300.5.530.","journal-title":"JAMA"},{"key":"4198_CR15","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1471-2334-9-42","volume":"9","author":"JK Varma","year":"2009","unstructured":"Varma JK, Nateniyom S, Akksilp S, Mankatittham W, Sirinak C, Sattayawuthipong W, Burapat C, Kittikraisak W, Monkongdee P, Cain KP, Wells CD, Tappero JW: HIV care and treatment factors associated with improved survival during TB treatment in Thailand: an observational study. BMC Infect Dis. 2009, 9: 42-10.1186\/1471-2334-9-42.","journal-title":"BMC Infect Dis"},{"key":"4198_CR16","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1086\/510078","volume":"44","author":"W Manosuthi","year":"2007","unstructured":"Manosuthi W, Ruxrungtham K, Likanonsakul S, Prasithsirikul W, Inthong Y, Phoorisri T, Sungkanuparph S: Nevirapine levels after discontinuation of rifampicin therapy and 60-week efficacy of nevirapine-based antiretroviral therapy in HIV-infected patients with tuberculosis. Clin Infect Dis. 2007, 44: 141-144. 10.1086\/510078.","journal-title":"Clin Infect Dis"},{"key":"4198_CR17","first-page":"360","volume":"13","author":"LK Shipton","year":"2009","unstructured":"Shipton LK, Wester CW, Stock S, Ndwapi N, Gaolathe T, Thior I, Avalos A, Moffat HJ, Mboya JJ, Widenfelt E, Essex M, Hughes MD, Shapiro RL: Safety and efficacy of nevirapine- and efavirenz-based antiretroviral treatment in adults treated for TB-HIV co-infection in Botswana. Int J Tuberc Lung Dis. 2009, 13: 360-366.","journal-title":"Int J Tuberc Lung Dis"},{"key":"4198_CR18","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1093\/cid\/cir447","volume":"53","author":"S Swaminathan","year":"2011","unstructured":"Swaminathan S, Padmapriyadarsini C, Venkatesan P, Narendran G, Ramesh Kumar S, Iliayas S, Menon PA, Selvaraju S, Pooranagangadevi NP, Bhavani PK, Ponnuraja C, Dilip M, Ramachandran R: Efficacy and safety of once-daily nevirapine- or efavirenz-based antiretroviral therapy in HIV-associated tuberculosis: a randomized clinical trial. Clin Infect Dis. 2011, 53: 716-724. 10.1093\/cid\/cir447.","journal-title":"Clin Infect Dis"},{"key":"4198_CR19","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1086\/599114","volume":"48","author":"W Manosuthi","year":"2009","unstructured":"Manosuthi W, Sungkanuparph S, Tantanathip P, Lueangniyomkul A, Mankatitham W, Prasithsirskul W, Burapatarawong S, Thongyen S, Likanonsakul S, Thawornwa U, Prommool V, Ruxrungtham K, the NR Study Team: A randomized trial comparing plasma drug concentrations and efficacies between 2 Non-nucleoside reverse-transcriptase inhibitor-based regimens in HIV-infected patients receiving rifampicin: the N 2 R study. Clin Infect Dis. 2009, 48: 1752-1759. 10.1086\/599114.","journal-title":"Clin Infect Dis"},{"key":"4198_CR20","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1093\/jac\/dkq411","volume":"66","author":"M Lamorde","year":"2011","unstructured":"Lamorde M, Byakika-Kibwika P, Okaba-Kayom V, Ryan M, Coakley P, Boffito M, Namakula R, Kalemeera F, Colebunders R, Back D, Khoo S, Merry C: Nevirapine pharmacokinetics when initiated at 200 mg or 400 mg daily in HIV-1 and tuberculosis co-infected Ugandan adults on rifampicin. J Antimicrob Chemother. 2011, 66: 180-183. 10.1093\/jac\/dkq411.","journal-title":"J Antimicrob Chemother"},{"key":"4198_CR21","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1086\/318706","volume":"32","author":"WM El-Sadr","year":"2001","unstructured":"El-Sadr WM, Perlman DC, Denning E, Matts JP, Cohn DL: A review of efficacy studies of 6-month short-course therapy for tuberculosis among patients infected with human immunodeficiency virus: differences in study outcomes. Clin Infect Dis. 2001, 32: 623-632. 10.1086\/318706.","journal-title":"Clin Infect Dis"},{"key":"4198_CR22","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1086\/651686","volume":"50","author":"FA Khan","year":"2010","unstructured":"Khan FA, Minion J, Pai M, Royce S, Burman W, Harries AD, Menzies D: Treatment of active tuberculosis in HIV-coinfected patients: a systematic review and meta-analysis. Clin Infect Dis. 2010, 50: 1288-1299. 10.1086\/651686.","journal-title":"Clin Infect Dis"},{"key":"4198_CR23","first-page":"197","volume":"14","author":"M Moses","year":"2010","unstructured":"Moses M, Zachariah R, Tayler-Smith K, Misinde D, Foncha C, Manzi M, Bauerfeind A, Mwagomba B, Kwanjana J, Harries AD: Outcomes and safety of concomitant nevirapine and rifampicin treatment under programme conditions in Malawi. Int J Tuberc Lung Dis. 2010, 14: 197-202.","journal-title":"Int J Tuberc Lung Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-13-482\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-13-482.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-13-482","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-13-482.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T11:24:10Z","timestamp":1688556250000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-13-482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,17]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["4198"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-13-482","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,17]]},"article-number":"482"}}